Developer docs
API playgroundTry for free, no card

Search company profiles

Merck India

Full company profile

uuid0026ap4

Namestring
Merck India
Legal namestring
Merck KGaA, Darmstadt, Germany
Websiteurl
merckgroup.com
Company typeenum
Public
Founded yearint
1967
Descriptiontext

Merck India is the Indian operations of Merck KGaA, Darmstadt, Germany, a science and technology multinational founded in 1668 and publicly traded on the Frankfurt Stock Exchange under ticker MRK. The group operates through three integrated sectors: Life Science, Healthcare, and Electronics. Its Life Science division supplies Process Solutions, Advanced Solutions, and Discovery Solutions to biopharmaceutical manufacturers and research institutions; its Healthcare division develops therapies in oncology, neurology and immunology, fertility, rare tumors, and cardiovascular, metabolic and endocrine conditions under brands including EMD Serono (US/Canada); and its Electronics division supplies thin films, optronics, formulations, metrology and inspection, specialty gases, delivery systems and services, and the Intermolecular custom-innovation platform to semiconductor and display manufacturers under the EMD Electronics (US/Canada) brand. Group consolidated revenue in FY2024 was EUR 21.2 billion, with 62,000+ employees across 65 countries; the India subsidiary operates out of Vikhroli with 1,001-5,000 employees and serves as one of the Asian hubs of the global enterprise.

The company monetizes primarily through B2B direct enterprise sales of high-specification products and therapeutic regimens, with deep qualification cycles in semiconductor materials and bioprocessing creating switching-cost stickiness. Major wholly-owned subsidiaries include MilliporeSigma (Life Science US/Canada), EMD Serono (Healthcare US/Canada), EMD Electronics (Electronics US/Canada), Intermolecular (custom semiconductor innovation), and — per the agreement announced 2025-06-25 — Bio-Techne (Life Sciences research tools, US$11.3 billion / EUR 9.9 billion). The technology stack spans proprietary mRNA platforms, AI-integrated R&D pipelines, and advanced semiconductor materials, supported by recent infrastructure investments such as the high-performance compute deployment in Munich (2025-11) with Lenovo and Equinix and renewable energy procurement for South Korea operations (2025-04) toward an 80% renewable electricity target by 2030.

Merck KGaA holds a KGaA legal structure with the E. Merck family as major shareholder and is distinct from Merck & Co., Inc., which holds MERCK trademark rights in the United States and Canada. The parent company has no parent company and operates the India subsidiary as part of its worldwide footprint. Marketing and distribution rely on direct sales, regional offices, a content-marketing blog (Vibrant Thoughts), events, news/media, and active social channels across LinkedIn, Instagram, X, and Facebook. Strategic emphasis in 2025 centers on consolidating Life Sciences market leadership through the Bio-Techne acquisition, scaling AI-enabled discovery and semiconductor process innovation, and broadening Asia-Pacific operational depth.

Short descriptiontext

Merck India is the Indian subsidiary of Merck KGaA, Darmstadt, Germany — a global science and technology company serving biopharma, healthcare, and semiconductor manufacturers across three integrated sectors: Life Science, Healthcare, and Electronics, with 62,000+ employees in 65 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersVikhroli, India
HQ citystring
Vikhroli
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
pharmaceutical products, life science solutions, biopharma manufacturing, semiconductor materials, electronics thin films
Industry1 code
PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
NAICS code2 codes
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers42345
  • Other Professional Equipment and Supplies Merchant Wholesalers423490
SIC code2 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Wholesale-Electronic Parts & Equipment, Nec5065
Product category
Specialty pharmaceuticals, life science, and electronics materials
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Merck India is the Indian subsidiary of Merck KGaA, Darmstadt, Germany, operating in three business divisions: Healthcare (pharmaceutical products in oncology, neurology & immunology, fertility, general medicine, and rare tumors), Life Science (biopharma and academic research products and services including Process Solutions, Advanced Solutions, and Discovery Solutions), and Electronics (semiconductor materials and solutions covering thin films, optronics, formulations, metrology and inspection, delivery systems and services, specialty gases, and Intermolecular). The company sells its own manufactured products and services directly to business customers in pharmaceuticals, research, and electronics manufacturing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Merck KGaA, Darmstadt, Germany is a vibrant science and technology company operating across three business sectors: Life Science, Healthcare, and Electronics. The company offers a diverse portfolio of products and services with over 62,000 employees across 65 countries. Life Science provides Process Solutions, Advanced Solutions, and Discovery Solutions for biopharmaceutical and research applications. Healthcare focuses on therapeutic areas including Oncology, Neurology & Immunology, Fertility, General Medicine, and Rare Tumors. Electronics offers technology solutions including Thin Films, Optronics, Formulations, Metrology and Inspection, Delivery Systems & Services, Specialty Gases, and Intermolecular® for semiconductors. In the US and Canada, the company operates under sub-brands: MilliporeSigma (life science), EMD Serono (healthcare), and EMD Electronics (electronics).

Product and service9 records
1Process Solutions (Life Science)
CategoryLife Science / Biopharma Manufacturing
Description

Process solutions for biopharmaceutical manufacturing covering bioprocessing, manufacturing chemistries, and process-related equipment and services for drug production customers.

2Advanced Solutions (Life Science)
CategoryLife Science / Biopharma Manufacturing
Description

Advanced life-science products and tools for complex biopharma and research workflows, designed for sophisticated drug development and manufacturing applications.

3Discovery Solutions (Life Science)
CategoryLife Science / Research
Description

Discovery solutions for life-science research and drug discovery, serving academic and biopharma research organizations.

4Healthcare pharmaceutical products (Oncology, Neurology & Immunology, Fertility, General Medicine, Rare Tumors)
CategoryHealthcare / Pharmaceuticals
Description

Prescription pharmaceutical products covering oncology, neurology & immunology, fertility, general medicine (cardiovascular, metabolism, endocrinology), and rare tumors, for treating physicians, hospitals and clinics.

5Electronics — Semiconductor materials (Thin Films, Optronics, Formulations)
CategoryElectronics / Semiconductor Materials
Description

Semiconductor materials including thin films, optronics materials, and formulations for electronics / semiconductor manufacturers.

6Electronics — Metrology and Inspection
CategoryElectronics / Semiconductor Materials
Description

Metrology and inspection solutions for semiconductor and electronics manufacturing customers to enable precision measurement and quality control.

7Electronics — Delivery Systems and Services
CategoryElectronics / Semiconductor Materials
Description

Delivery systems and related services for electronics manufacturing materials handling and deployment.

8Electronics — Specialty Gases
CategoryElectronics / Specialty Gases
Description

Specialty gases supplied to electronics and semiconductor manufacturers for production processes.

9Intermolecular (Electronics)
CategoryElectronics / Semiconductor Materials
Description

Intermolecular offering under Electronics for semiconductor and materials innovation customers.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Merck India

Specialty pharmaceuticals, life science, and electronics materialsmerckgroup.com

Merck India is the Indian subsidiary of Merck KGaA, Darmstadt, Germany — a global science and technology company serving biopharma, healthcare, and semiconductor manufacturers across three integrated sectors: Life Science, Healthcare, and Electronics, with 62,000+ employees in 65 countries.

What Merck India does

Merck India is the Indian operations of Merck KGaA, Darmstadt, Germany, a science and technology multinational founded in 1668 and publicly traded on the Frankfurt Stock Exchange under ticker MRK. The group operates through three integrated sectors: Life Science, Healthcare, and Electronics. Its Life Science division supplies Process Solutions, Advanced Solutions, and Discovery Solutions to biopharmaceutical manufacturers and research institutions; its Healthcare division develops therapies in oncology, neurology and immunology, fertility, rare tumors, and cardiovascular, metabolic and endocrine conditions under brands including EMD Serono (US/Canada); and its Electronics division supplies thin films, optronics, formulations, metrology and inspection, specialty gases, delivery systems and services, and the Intermolecular custom-innovation platform to semiconductor and display manufacturers under the EMD Electronics (US/Canada) brand. Group consolidated revenue in FY2024 was EUR 21.2 billion, with 62,000+ employees across 65 countries; the India subsidiary operates out of Vikhroli with 1,001-5,000 employees and serves as one of the Asian hubs of the global enterprise.

The company monetizes primarily through B2B direct enterprise sales of high-specification products and therapeutic regimens, with deep qualification cycles in semiconductor materials and bioprocessing creating switching-cost stickiness. Major wholly-owned subsidiaries include MilliporeSigma (Life Science US/Canada), EMD Serono (Healthcare US/Canada), EMD Electronics (Electronics US/Canada), Intermolecular (custom semiconductor innovation), and — per the agreement announced 2025-06-25 — Bio-Techne (Life Sciences research tools, US$11.3 billion / EUR 9.9 billion). The technology stack spans proprietary mRNA platforms, AI-integrated R&D pipelines, and advanced semiconductor materials, supported by recent infrastructure investments such as the high-performance compute deployment in Munich (2025-11) with Lenovo and Equinix and renewable energy procurement for South Korea operations (2025-04) toward an 80% renewable electricity target by 2030.

Merck KGaA holds a KGaA legal structure with the E. Merck family as major shareholder and is distinct from Merck & Co., Inc., which holds MERCK trademark rights in the United States and Canada. The parent company has no parent company and operates the India subsidiary as part of its worldwide footprint. Marketing and distribution rely on direct sales, regional offices, a content-marketing blog (Vibrant Thoughts), events, news/media, and active social channels across LinkedIn, Instagram, X, and Facebook. Strategic emphasis in 2025 centers on consolidating Life Sciences market leadership through the Bio-Techne acquisition, scaling AI-enabled discovery and semiconductor process innovation, and broadening Asia-Pacific operational depth.

Merck India firmographics

Firmographics
Name
Merck India
Legal name
Merck KGaA, Darmstadt, Germany
Website
https://merckgroup.com
Company type
Public
Founded year
1967
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Merck India is the Indian subsidiary of Merck KGaA, Darmstadt, Germany — a global science and technology company serving biopharma, healthcare, and semiconductor manufacturers across three integrated sectors: Life Science, Healthcare, and Electronics, with 62,000+ employees in 65 countries.
Ownership category
akta.pro rank

Merck India industry classification

Industry
Product category
Specialty pharmaceuticals, life science, and electronics materials
NAICS
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345), Other Professional Equipment and Supplies Merchant Wholesalers (423490)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Wholesale-Electronic Parts & Equipment, Nec (5065)
akta.pro industry
PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)

Keywords

  • Pharmaceutical products
  • Life science solutions
  • Biopharma manufacturing
  • Semiconductor materials
  • Electronics thin films

Where Merck India is headquartered

Location

Headquarters

HQ city
Vikhroli
HQ country
India
HQ region
Asia

Markets served

Merck India business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

Merck India product offering

Product offering

Core offering

Merck India is the Indian subsidiary of Merck KGaA, Darmstadt, Germany, operating in three business divisions: Healthcare (pharmaceutical products in oncology, neurology & immunology, fertility, general medicine, and rare tumors), Life Science (biopharma and academic research products and services including Process Solutions, Advanced Solutions, and Discovery Solutions), and Electronics (semiconductor materials and solutions covering thin films, optronics, formulations, metrology and inspection, delivery systems and services, specialty gases, and Intermolecular). The company sells its own manufactured products and services directly to business customers in pharmaceuticals, research, and electronics manufacturing.

Product overview

Merck KGaA, Darmstadt, Germany is a vibrant science and technology company operating across three business sectors: Life Science, Healthcare, and Electronics. The company offers a diverse portfolio of products and services with over 62,000 employees across 65 countries. Life Science provides Process Solutions, Advanced Solutions, and Discovery Solutions for biopharmaceutical and research applications. Healthcare focuses on therapeutic areas including Oncology, Neurology & Immunology, Fertility, General Medicine, and Rare Tumors. Electronics offers technology solutions including Thin Films, Optronics, Formulations, Metrology and Inspection, Delivery Systems & Services, Specialty Gases, and Intermolecular® for semiconductors. In the US and Canada, the company operates under sub-brands: MilliporeSigma (life science), EMD Serono (healthcare), and EMD Electronics (electronics).

Differentiator

Problem solved

Functional benefit

Products and services

  • Process Solutions (Life Science) Process solutions for biopharmaceutical manufacturing covering bioprocessing, manufacturing chemistries, and process-related equipment and services for drug production customers.
  • Advanced Solutions (Life Science) Advanced life-science products and tools for complex biopharma and research workflows, designed for sophisticated drug development and manufacturing applications.
  • Discovery Solutions (Life Science) Discovery solutions for life-science research and drug discovery, serving academic and biopharma research organizations.
  • Healthcare pharmaceutical products (Oncology, Neurology & Immunology, Fertility, General Medicine, Rare Tumors) Prescription pharmaceutical products covering oncology, neurology & immunology, fertility, general medicine (cardiovascular, metabolism, endocrinology), and rare tumors, for treating physicians, hospitals and clinics.
  • Electronics — Semiconductor materials (Thin Films, Optronics, Formulations) Semiconductor materials including thin films, optronics materials, and formulations for electronics / semiconductor manufacturers.
  • Electronics — Metrology and Inspection Metrology and inspection solutions for semiconductor and electronics manufacturing customers to enable precision measurement and quality control.
  • Electronics — Delivery Systems and Services Delivery systems and related services for electronics manufacturing materials handling and deployment.
  • Electronics — Specialty Gases Specialty gases supplied to electronics and semiconductor manufacturers for production processes.
  • Intermolecular (Electronics) Intermolecular offering under Electronics for semiconductor and materials innovation customers.

Companies that use Merck India

Customer profile

Segments3 records

Ideal customer profiles3 records

Merck India technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Merck India partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights6 records

Merck India competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

Merck India social profiles

Digital presence

Merck India financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Merck India leadership team

Management profile

Number of profiles

Profiles2 records

Merck India subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Merck India funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Merck India M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merck India

What does Merck India do?

Merck India is the Indian subsidiary of Merck KGaA, Darmstadt, Germany, operating in three business divisions: Healthcare (pharmaceutical products in oncology, neurology & immunology, fertility, general medicine, and rare tumors), Life Science (biopharma and academic research products and services including Process Solutions, Advanced Solutions, and Discovery Solutions), and Electronics (semiconductor materials and solutions covering thin films, optronics, formulations, metrology and inspection, delivery systems and services, specialty gases, and Intermolecular). The company sells its own manufactured products and services directly to business customers in pharmaceuticals, research, and electronics manufacturing.

Is Merck India a public or private company?

Merck India is a public company. It is classified as corporate owned and is currently operating.

When was Merck India founded?

Merck India was founded in 1967. It employs 1,001 to 5,000 people.

Where is Merck India based?

Merck India is headquartered in Vikhroli, India, in the Asia region.

Does Merck India have an API?

No public API is recorded for Merck India.

What industry is Merck India in?

Merck India's product category is Specialty pharmaceuticals, life science, and electronics materials. Its primary akta.pro industry code is HLAGADAK, Material Characterization & Spectroscopy (NMR/FTIR/MS). Its NAICS code is 42345 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IndianpharmapostMerck India, MAHE launch catalyst program to build future R&D talent pipelineMerck India and Manipal Academy of Higher Education (MAHE) signed a Memorandum of Understanding to launch the 'Catalyst' program, a three-month training initiative aimed at building a future-ready talent pipeline for the healthcare sector. The partnership leverages MAHE's academic ecosystem and Merck's subject matter experts to provide students with practical skills in research and development domains.Business TodayMerck India expands infrastructure to capitalise on growing pharmaceutical industryMerck India is expanding its infrastructure, including a partnership with the Heavy Water Board, to address the growing market for deuterated raw compounds. The market is currently valued at around $100 million with potential to reach $1 billion over the next 5-10 years. Merck plans further investments at its Jigani plant in Bengaluru over the next 1-3 years.NewswireERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)Merck announced that ERBITUX (cetuximab) received NMPA approval in China for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma with platinum-based fluorouracil therapy. The approval is based on the CHANGE II study, which showed improved progression-free survival, overall survival, and response rate compared to chemotherapy alone.FiercePharmaAZ, Merck match Clovis with Lynparza 'priority' boost in prostate cancerThe FDA granted priority review to Merck and AstraZeneca's Lynparza for prostate cancer, with approval expected in Q2. The decision is based on a phase 3 trial showing a 66% risk reduction in disease progression or death among patients with BRCA1, BRCA2, or ATM mutations.FiercePharmaJPM: Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openingsMerck is using contract manufacturers to address Gardasil supply constraints amid skyrocketing demand. The company borrowed doses from the CDC stockpile, costing about $120 million in Q4 sales, and expects two new bulk plants around 2023 to meet global needs. Gardasil sales rose 34% year-over-year in the first nine months of 2019.PrwebGlucoMe and Merck to Present Digital Diabetes Management Outcomes at the Upcoming IDF Congress 2019 in South KoreaGlucoMe and Merck will present digital diabetes management outcomes at the IDF Congress in South Korea in December 2019. The study, conducted in Vietnam, showed patients reduced HbA1c levels in 12 weeks, with average blood glucose dropping 19.5 mg/dl and 81% retention.FiercePharmaIn crowded MS market, Merck KGaA's Mavenclad now offsets Rebif declineMerck KGaA's Mavenclad generated €89 million in third-quarter sales, up 45% year over year, offsetting Rebif's 15.1% decline to €318 million. The oral MS drug's growth is attributed to positive sales dynamics in both the U.S. and Europe, with Merck expecting full-year sales to reach €300 million.